• Citer

Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group

par Brandão, Mariana;Prisciandaro, Elena;Xenophontos, Eleni;Mariolo, Alessio;Sadeghi, Amir H.;Filippi, Andrea R.;Levy, Antonin;Bandura, Artur;Caramella, Caroline;Dickhoff, Chris;de Margerie-Mellon, Constance;Faivre-Finn, Corinne;Portik, Daniel;Sanchez-Lorente, David;Ruysscher, Dirk De;Smit, Egbert;Gobbini, Elisa;Fadel, Elie;Ruffini, Enrico;Olmetto, Emanuela;Cortiula, Francesco;Bahce, Idris;Houda, Ilias;Opitz, Isabelle;Naidoo, Jarushka;Edwards, John;Remon, Jordi;Benitez, José Carlos;Trujillo, Juan Carlos;Derks, Jules;Amrane, Karim;Hartemink, Koen;Stathopoulos, Konstantinos;Hendriks, Lizza E.L.;Iglesias, Manoli;Occhipinti, Mario;Guckenberger, Matthias;Levra, Niccolo Giaj;Girard, Nicolas;Reguart, Noemi;Mercier, Olaf;Bironzo, Paolo;Hofman, Paul;Petersen, Rene Horsleben;Angelis, Riccardo De;Abgral, Ronan;Terrisse, Safae;Popat, Sanjay;Pierret, Thomas;Blum, Torsten Gerriet;Ricardi, Umberto;Dionisi, Valeria;Berghmans, Thierry ;Dingemans, Anne-Marie C.
Référence Lung cancer, page (108798)
Publication Publié, 2025-10-01

Article révisé par les pairs

• Accès en ligne
• Détails
• Statistiques